News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Inovio, Regeneron Plan Clinical Trial of Triple-Combo Immunotherapy for Brain Tumors

Al's Comment:

 I love this kind of combination - tries to cover all of the bases.  I wish them luck.  However, I am trying to change the system - it should be legal for a doctor to try this type of combination outside of trials.  What happens if they determine that a different drug might do better if they switch it out for the one they chose now?  It is back to the drawing board - design and set up another trial - waste a year or 2, and loads of money.  There is a better way.


Posted on: 05/11/2017

Inovio, Regeneron Plan Clinical Trial of Triple-Combo Immunotherapy for Brain Tumors

 

https://immuno-oncologynews.com/2017/05/11/inovio-and-regeneron-to-test-triple-combo-immunotherapy-in-brain-cancer-trial/

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740